Advances in imaging have given radiology an increasingly significant role in the diagnosis, staging and re-staging of patients with urinary tract tumors. In this chapter we emphasize the value of current imaging and briefly discuss the potential applications of novel imaging techniques in the management of patients with urinary tract tumors. We will focus primarily on renal cell tumors and bladder transitional cell cancers. Multi-detector-row CT (MDCT) offers greater speed, improved spatial resolution and wider coverage, and allows screening of multiple organs in the abdomen for metastatic disease and for complications. MRI, with its superior soft tissue resolution, offers advantages in imaging some urinary tumors. Ultrasound can also play a complementary role to CT or MRI in imaging of urinary tumors. We will limit discussion of nuclear medicine techniques, but will mention the emerging role of FDG-PET and Positron Emission Tomography/CT (PET/CT) for the detection of distant metastases of several GU malignancies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Cancer Society. Cancer facts and figures 2006. Atlanta (GA): American Cancer Society; 2006
Bosniak MA. Observation of small incidentally detected renal masses. Semin Urol Oncol. 1995;13(4):267–272.
Kassouf W, Aprikian AG, Laplante M, et al. Natural history of renal masses followed expectantly. J Urol. 2004;171(1):111–113.
Beck SD, Patel MI, Snyder ME, et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol. 2004;11(1):71–77.
McKiernan J, Yossepowitch O, Kattan MW, et al. Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. Urology. 2002;60(6):1003–1009.
Zhang J, Lefkowitz RA, Bach A. Imaging of Kidney Cancer. Radiologic Clinics of North America 2007 45 (1) 119–147.
Yuh BI, Cohan RH, Francis IR, et al. Comparison of nephrographic with excretory phase helical computed tomography for detecting and characterizing renal masses. Can Assoc Radiol J. 2000;51(3):170–176.
Yuh BI, Cohan RH. Different phases of renal enhancement: role in detecting and characterizing renal masses during helical CT. AJR Am J Roentgenol. 1999;173(3):747–755.
Kopka L, Fischer U, Zoeller G, et al. Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma. AJR Am J Roentgenol. 1997;169(6):1573–1578.
Herts BR, Coll DM, Novick AC, et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol. 2002;178(2):367–372.
Sheir KZ, El-Azab M, Mosbah A, et al. Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol. 2005;174(2):451–455
Prasad SR, Humphrey PA, Catena JR, et al. Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics. 2006 Nov-Dec;26(6):1795–806
Birnbaum BA, Maki DD, Chakraborty DP, et al.. Renal cyst pseudo enhancement: evaluation with an anthropomorphic body CT phantom. Radiology. 2002;225(1):83–90.
Abdulla C, Kalra MK, Saini S, et al. Pseudo enhancement of simulated renal cysts in a phantom using different multidetector CT scanners. AJR Am J Roentgenol. 2002;179(6):1473–1476.
Bosniak MA. The current radiological approach to renal cysts. Radiology. 1986; 158(1):1–10.
Eble JN, Bonsib SM. Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin Diagn Pathol. 1998;15(1):2–20.
Brinker DA, Amin MB, de Peralta-Venturina M, et al. Extensively necrotic cystic renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal cancers. Am J Surg Pathol. 2000;24(7):988–995.
Semelka RC, Shoenut JP, Kroeker MA, et al. Renal lesions: controlled comparison between CT and 1.5-T MRI with non-enhanced and gadolinium-enhanced fat-suppressed spin-echo and breath hold FLASH techniques. Radiology. 1992;182(2):425–430.
Scialpi M, Di Maggio A, Midiri M, et al.. Small renal masses: assessment of lesion characterization and vascularity on dynamic contrast-enhanced MRI with fat suppression. AJR Am J Roentgenol. 2000;175(3):751–757.
Pretorius ES, Siegelman ES, Ramchandani P, et al. Renal neoplasms amenable to partial nephrectomy: MRI. Radiology. 1999;212(1):28–34.
Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. M. Gadodiamide-assocaited nephrogenic systemic fibrosis: why radiologists should be concerned. Am J Roentgenol. 2007;188(2):586–92.
Elizabeth A. Sadowski, Lindsey K. Bennett, Micah R. Chan, Andrew L. Wentland, Andrea L. Garrett, Robert W. Garrett, and Arjang Djamali Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation Radiology 2007 243: 148–157
Eilenberg SS, Lee JK, Brown J, et al. Renal masses: evaluation with gradient-echo Gd-DTPA-enhanced dynamic MRI. Radiology. 1990;176(2):333–338.
Fein AB, Lee JK, Balfe DM, et al. Diagnosis and staging of renal cell carcinoma: a comparison of MRI and CT. AJR Am J Roentgenol. 1987;148(4):749–753.
Ho VB, Allen SF, Hood MN, et al.. Renal masses: quantitative assessment of enhancement with dynamic MRI. Radiology. 2002;224(3):695–700.
Israel GM, Hindman N, Bosniak MA. Evaluation of cystic renal masses: comparison of CT and MRI by using the Bosniak classification system. Radiology. 2004;231(2):365–371.
Forman HP, Middleton WD, Melson GL, et al. Hyperechoic renal cell carcinomas: increase in detection at US. Radiology. 1993;188(2):431–434.
Prasad SR, Saini S, Stewart S, et al. CT characterization of “indeterminate” renal masses: targeted or comprehensive scanning?. J Comput Assist Tomogr. 2002;26(5):725–727.
Warshauer DM, McCarthy SM, Street L, et al. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology. 1988;169(2):363–365.
Jamis-Dow CA, Choyke PL, Jennings SB, et al. Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology. 1996;198(3):785–788.
Aide N, Cappele O, Bottet P, et al. Efficiency of [(18) F] FDG-PET in characterizing renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging. 2003;30(9):1236–1245.
Montravers F, Grahek D, Kerrou K, et al. Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera. J Nucl Med. 2000;41(1):78–84.
Ramdave S, Thomas GW, Berlangieri SU, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol. 2001;166(3):825–830.
Blake MA, McKernan M, Setty B, et al. Renal oncocytoma displaying intense activity on 18F-FDG PET. AJR Am J Roentgenol. 2006;186(1):269–270.
Schoder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med. 2004;34(4):274–292.
Javidan J, Stricker HJ, Tamboli P, et al.. Prognostic significance of the 1997 TNM classification of renal cell carcinoma. J Urol. 1999;162(4):1277–1281.
Kidney. In: American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th edition. New York: Springer; 2002;p. 323–325.
Johnson CD, Dunnick NR, Cohan RH, et al. Renal adenocarcinoma: CT staging of 100 tumors. AJR Am J Roentgenol. 1987;148(1):59–63.
Roy C, El Ghali S, Buy X, et al.. Significance of the pseudocapsule on MRI of renal neoplasms and its potential application for local staging: a retrospective study. AJR Am J Roentgenol. 2005;184(1):113–120.
Semelka RC, Shoenut JP, Magro CM, et al. Renal cancer staging: comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MRI. J Magn Reson Imaging. 1993;3(4):597–602.
Didier D, Racle A, Etievent JP, et al. Tumor thrombus of the inferior vena cava secondary to malignant abdominal neoplasms: US and CT evaluation. Radiology. 1987;162(1 Pt 1):83–89.
Studer UE, Scherz S, Scheidegger J, et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol. 1990;144(2 Pt 1):243–245.
Hilton S. Imaging of renal cell carcinoma. Semin Oncol. 2000;27(2):150–159.
Raptopoulos VD, Blake SP, Weisinger K, et al. Multiphase contrast-enhanced helical CT of liver metastases from renal cell carcinoma. Eur Radiol. 2001;11(12):2504–2509.
Rabbani F, Herr HW, Almahmeed T, et al. Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors. J Clin Oncol. 2002;20(9):2370–2375.
Barentsz JO, Witjes JA, Ruijs JH. What is new in bladder cancer imaging? Urol Clin North Am 1997; 24: 583–602.
MacVicar AD. Bladder cancer staging. BJU Int 2000; 86 [suppl 1]: 111–122.
Barentsz JO, Jager GJ, Witjes JA, et al. Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT. Eur Radiol 1996; 6:129–133.
Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19:666–675.
Kim J K, Park SY, Ahn HJ, et al. Bladder Cancer: Analysis of Multi–Detector Row Helical CT Enhancement Pattern and Accuracy in Tumor Detection and Perivesical Staging. Radiology 2004; 231:725–731.
Kundra V, Silverman PM. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder. AJR Am J Roentgenol. 2003; 180(4): 1045–54.
Ellis JH, McCullough NB, Francis IR, et al. Transitional cell carcinoma of the bladder: patterns of recurrence after cystectomy as determined by CT. AJR Am J Roentgenol. 1991; 157(5): 999–1002.
Vinnicombe SJ, Norman AR, Nicholson V, et al. Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography. Radiology 1995; 194:349–55
Husband JE, Robinson L, Thomas G. Contrast enhancing lymph nodes in bladder cancer: a potential pitfall on CT. Clin Radiol. 1992; 45(6): 395–8.
Kim B, Semelka RC, Ascher SM, et al. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MRI, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 1994; 193: 239–245.
Maeda H, Kinukawa T, Hattori R, et al. Detection of muscle layer invasion with sub millimeter pixel MR images: staging of bladder carcinoma. Magn Reson Imaging 13:9, 1995.
Tekes A, Kamel I, Imam K, et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol. 2005; 184 (1): 121–7.
Lammle M, Beer A, Settles M, et al. Reliability of MRI-based virtual cystoscopy in the diagnosis of cancer of the urinary bladder. AJR Am J Roentgenol. 2002; 178(6): 1483–8.
Kawai N, Mimura T, Nagata D, et al. Intravenous urography-virtual cystoscopy is a better preliminary examination than air virtual cystoscopy. BJU Int. 2004; 94(6): 832–6.
Tsili ACh, Tsampoulas C, Chatziparaskevas N, et al. Computed tomographic virtual cystoscopy for the detection of urinary bladder neoplasms. Eur Urol. 2004; 46(5): 579–85.
Nambirajan T, Sohaib SA, Muller-Pollard C, et al. Virtual cystoscopy from computed tomography: a pilot study. BJU Int. 2004; 94(6): 828–31.
Kawashima A, Glockner JF, King BF Jr. CT urography and MR urography. Radiol Clin North Am. 2003; 41(5): 945–61.
Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans L. FDG-PET for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging. 2005; 32(12): 1412–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Blake, M.A., Kalra, M.K. (2008). Imaging of Urinary Tract Tumors. In: Blake, M.A., Kalra, M.K. (eds) Imaging in Oncology. Cancer Treatment and Research, vol 143. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-75587-8_12
Download citation
DOI: https://doi.org/10.1007/978-0-387-75587-8_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-75586-1
Online ISBN: 978-0-387-75587-8
eBook Packages: MedicineMedicine (R0)